Recombinant PrP production for RT-QuIC analysis

VR Veronica Redaelli
EB Edoardo Bistaffa
GZ Gianluigi Zanusso
GS Giulia Salzano
LS Luca Sacchetto
MR Martina Rossi
CL Chiara Maria Giulia De Luca
MB Michele Di Bari
SP Sara Maria Portaleone
UA Umberto Agrimi
GL Giuseppe Legname
IR Ignazio Roiter
GF Gianluigi Forloni
FT Fabrizio Tagliavini
FM Fabio Moda
request Request a Protocol
ask Ask a question
Favorite

Truncated Bank voles PrP (BvPrP(90-231)) construct was purchased from GenScript. The construct was expressed in Escherichia coli BL21 (DE3) cells (Stratagene). Freshly transformed overnight culture was inoculated into Luria Bertani (LB) medium and 100 μg/mL ampicillin. At 0.8 OD600 expression was induced with isopropyl b-D galactopyranoside (IPTG) to a final concentration of 0.75 mM. Cells were grown in a BioStat-B plus fermentor (Sartorius). The cells were lysed by a homogenizer (PandaPLUS 2000) and the inclusion bodies were suspended in buffer containing 25 mM Tris-HCl, 5 mM EDTA, 0.8% TritonX100, pH 8, and then in bi-distilled water several times. Inclusion bodies containing BvPrP(90-231) were dissolved in 5 volumes of 8 M guanidine hydrochloride (GndHCl), loaded onto pre-equilibrated HiLoad 26/60 Superdex 200-pg column, and eluted in 25 mM Tris–HCl (pH 8), 5 mM ethylenediaminetetraacetic acid (EDTA), and 6 M GndHCl at a flow/rate of 2 mL/min. Proteins refolding was performed by dialysis against refolding buffer (20 mM sodium acetate and 0.005% NaN3 (pH 5.5)) using a Spectrapor membrane. Purified protein was analyzed by SDS-polyacrylamide gel electrophoresis under reducing conditions and Western blot.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A